Can buprenorphine (Subutex) tests yield false positive results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 30, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

False positive results for buprenorphine can occur due to cross-reactivity with other substances or laboratory errors. These false positives may happen in immunoassay screening tests, which are more prone to cross-reactivity with unrelated substances in the urine, as noted in a study on drug testing in children and adolescents 1.

Key Points to Consider

  • Cross-reactivity with certain medications, such as fluoroquinolone antibiotics, can lead to false-positive results for opiates, which may include buprenorphine, although specific cross-reactivity with buprenorphine is not detailed in the provided study 1.
  • Confirmatory tests, such as gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS), are highly unlikely to yield false-positive results and should be used to verify screening test results.
  • Healthcare providers must consider a patient's complete medical history, including prescribed medications, to accurately interpret drug test results and avoid misinterpretation due to potential cross-reactivity or other factors 1.

Clinical Implications

  • When a buprenorphine test result is positive, especially if unexpected, it is crucial to follow up with a confirmatory test to rule out false positives.
  • The limitations of drug testing, including the potential for false positives and the inability to distinguish between appropriate use and misuse of prescribed medications, must be understood by practitioners 1.
  • Accurate interpretation of drug test results requires knowledge of the selected matrix, the substances for which the drug panel tests, and potential cross-reactivity, as well as the patient's clinical context and medication history.

From the Research

False Positive Results for Buprenorphine

  • False positive results for buprenorphine can occur due to various factors, including instrumental carry-over 2 and cross-reactivity with other substances 3, 4, 5.
  • The CEDIA buprenorphine assay can produce false positive results due to cross-reactivity with codeine, morphine, and their metabolites 3.
  • Tramadol use can also cause false positive urine buprenorphine results, with the effect being assay-dependent 4.
  • High-dose morphine can produce false-positive buprenorphine EIAs with standard urine EIA toxicology testing 5.
  • Increasing the cutoff value for the CEDIA buprenorphine assay can increase the diagnostic accuracy and reduce false positive results 3.

Substances Causing False Positive Results

  • Codeine and its metabolites can cause false positive results for buprenorphine 3.
  • Morphine and its metabolites can cause false positive results for buprenorphine 3, 5.
  • Tramadol can cause false positive results for buprenorphine 4.
  • High-dose morphine can cause false positive results for buprenorphine 5.

Assay Dependence

  • The effect of false positive results can be assay-dependent, with different assays producing different results for the same substance 4.
  • The CEDIA buprenorphine assay can produce false positive results due to cross-reactivity with other substances, while other assays may not 3, 4.

Related Questions

In a patient taking tramadol daily, why might buprenorphine appear on a urine drug screen?
In a patient prescribed morphine extended-release and Percocet (oxycodone/acetaminophen), where would low‑level buprenorphine be detected?
Does ketamine produce a positive result for buprenorphine on a standard urine drug screen?
What are the next steps after a false positive buprenorphine (Suboxone) result on a point-of-care (POC) urine toxicology test?
Can Suboxone (buprenorphine) cause a positive result on an opioid drug test?
What is the required timeframe for reporting a Serious Adverse Event (SAE) to the local Institutional Review Board (IRB) after becoming aware of the event?
What is the mechanism of action of Lokelma (sodium zirconium cyclosilicate)?
What action should be taken upon discovery of a participant's death in a clinical trial?
Is the severity of an Adverse Event (AE) equivalent to its seriousness?
Which adverse event feature is not used to determine expedited reporting to the Food and Drug Administration (FDA) by the Sponsor: seriousness, expectedness, causal relationship, or severity?
In which situation is a Serious Adverse Event (SAE) not required to be reported to the National Institute on Drug Abuse (NIDA) or designee within 24 hours: A. The investigator considers the SAE unrelated to study intervention, B. The SAE is non-fatal and non-life-threatening, C. The SAE occurs in a behavioral study, D. The SAE occurs in a non-Investigational New Drug (IND) study, E. The SAE occurs in the post-treatment observation period, or F. None of the above?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.